Impact of the COVID-19 Pandemic on Colorectal and Prostate Cancer Screening in a Large U.S. Health System
1
Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL 32610, USA
2
Department of Biostatistics, College of Public Health and Health Professions, University of Florida, Gainesville, FL 32610, USA
*
Author to whom correspondence should be addressed.
Academic Editors: Giuseppe Di Martino, Tommaso Staniscia, Fabrizio Cedrone and Andrea Tittarelli
Healthcare 2022, 10(2), 264; https://doi.org/10.3390/healthcare10020264
Received: 19 December 2021
/
Revised: 27 January 2022
/
Accepted: 28 January 2022
/
Published: 29 January 2022
(This article belongs to the Special Issue The Impact of COVID-19 on Healthcare Services)
During the first year of the coronavirus disease 2019 (COVID-19) pandemic, prevention measures included quarantining and facility closures. Because cancer screening is dependent on interventions in facilities, the extent of the COVID-19 impact on screening was questioned. A claims registry from a large health system was queried for colorectal and prostate cancer screening. A screening gap and screening loss ratio were calculated by comparing 2020 screening to historical reference years. All cancer screenings decreased in the first four months of the pandemic. Colorectal cancer screening returned to baseline in the latter six months of 2020. Prostate cancer screening exceeded baseline in the latter six months, but with a lesser gain than previous years. Populations disproportionately affected by decreased cancer screening included men and black people. To catch-up after the initial deficit in screening, it is estimated that the rate of colorectal cancer screening needs to increase by 50%.
View Full-Text
Keywords:
cancer screening; colorectal cancer; prostate cancer; COVID-19; health disparities; health policy; public health
▼
Show Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
- Supplementary File 1:
ZIP-Document (ZIP, 86 KiB)
MDPI and ACS Style
Kelkar, A.H.; Zhao, J.; Wang, S.; Cogle, C.R. Impact of the COVID-19 Pandemic on Colorectal and Prostate Cancer Screening in a Large U.S. Health System. Healthcare 2022, 10, 264. https://doi.org/10.3390/healthcare10020264
AMA Style
Kelkar AH, Zhao J, Wang S, Cogle CR. Impact of the COVID-19 Pandemic on Colorectal and Prostate Cancer Screening in a Large U.S. Health System. Healthcare. 2022; 10(2):264. https://doi.org/10.3390/healthcare10020264
Chicago/Turabian StyleKelkar, Amar H., Jing Zhao, Shu Wang, and Christopher R. Cogle. 2022. "Impact of the COVID-19 Pandemic on Colorectal and Prostate Cancer Screening in a Large U.S. Health System" Healthcare 10, no. 2: 264. https://doi.org/10.3390/healthcare10020264
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
